Janux Therapeutics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 100k | 24.44 |
| 2025-06-30 | $1.3M | 55k | 23.10 |
| 2025-03-31 | $3.8M | 142k | 27.00 |
| 2024-12-31 | $9.1M | 170k | 53.54 |
| 2024-09-30 | $4.9M | 107k | 45.43 |
| 2024-06-30 | $4.5M | 107k | 41.89 |
| 2024-03-31 | $3.9M | 105k | 37.65 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB